@DietBeginsMon Sick take. Clearly didn’t watch NAW go cold as ice in the playoffs last year while Randle played up. Not to mention the bevy of guys we have that play 2. Just unfortunate that Julius backslid hard the 2nd half of this year. The lack of effort felt contagious.
If you are going to intentionally foul not once but twice down 12 with 33 seconds...and shoot a 3 with 10.4 seconds (Murray could have dribbled the clock out)...you shouldn't be complaining about a layup at the end of the game. I'm just saying.
Why aren’t any of these at risk hospitals publishing their full accounting so everyone can see where they spend their money ?
All but one group of hospitals that I have looked at potentially investing in, spend so much on consultants and fees that it’s no wonder they are at risk
Plus, I have NEVER seen an industry that is worse than hospitals when it comes to buying medications and items like implants, screws, other devices. They overpay for everything.
And then when you show them how to save money, their “supply chain” employees resist any change.
They are so set in their ways, it’s a shock more don’t go out of business.
Prove me wrong.
Common theme - party with lower leverage agrees to surprising contract language stipulated by party with higher leverage. All roads continue to point to consolidation to increase leverage. 🤷♂️
@DutchRojas@eljefe1america Make enough money that you’re personally satisfied, able to meet payroll and other overhead obligations, while not sacrificing patient outcomes. Idk? Seems like something you know when you see…
@eljefe1america@DutchRojas The issue is most doctors are not good business operators. Frankly it’s not their fault. It seems more and more evident that private equity is the scourge of healthcare. The whole system needs to be reworked.
@eljefe1america@DutchRojas They’re playing the game by the rules as they’re written. Payers, institutions, and manufacturers always adapt to changing rules.
@dp_oneill Yeah certainly could see payers use any leverage to make the process onerous. One look at MLR growth and you can see why if they’re publicly traded. All of these delays have real impacts on beneficiaries ultimately depending on the care.
@Jeffery1313@mcuban@costplusdrugs A little disingenuous to boil it down to leverage. Like you’re acknowledging his point that a sick game is played based on covered lives. But you gloss over this. Your point about certain classes being easier than others is spot on, but it’s X so you have to score cool pts